Mark Douglas

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells

Olivier De Henau, Matthew Rausch, David A. Winkler et al. · Nature · 2016 · 843 citations

Hematological Malignancy, Blockade Therapy, Immunology +7

Techno-economic study of CO2 capture from an existing coal-fired power plant: MEA scrubbing vs. O2/CO2 recycle combustion

Diksha Singh, Eric Croiset, Peter Douglas et al. · Energy Conversion and Management · 2003 · 534 citations

Carbon Sequestration, O2/co2 Recycle Combustion, Engineering +11

Combustion characteristics of coal in a mixture of oxygen and recycled flue gas

Yewen Tan, Eric Croiset, Mark Douglas et al. · Fuel · 2005 · 396 citations

Chemical Engineering, Clean Coal Technology, Engineering +9

Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma

Steven M. Horwitz, Raphael Koch, Pierluigi Porcu et al. · Blood · 2017 · 274 citations · Full text

Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies

Ian W. Flinn, Susan O’Brien, Brad S. Kahl et al. · Blood · 2017 · 250 citations · Full text